fda approved glp-1 agonists Comparing Ozempic, Wegovy and Other Drugs FDA-Approved Dosages and Indications for
Description
Semaglutide and NT-proBNP in obesity-related HFpEF: insights from the STEP-HFpEF program

Candidates like Eli Lillys retatrutide and Amgens MariTide are raising the bar, with Phase II trials showing weight loss exceeding 24%, a level comparable to that achieved with bariatric surgery

Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stress

Well cover them all here
The 2.5 mg dose is not intended for chronic weight management